Digital Transformation And Telehealth Will Revolutionize Healthcare Collaboration

AN
AnalystHighTarget
AnalystHighTarget
Not Invested
Consensus Narrative from 18 Analysts
Published
23 Apr 25
Updated
23 Jul 25
AnalystHighTarget's Fair Value
US$78.58
15.3% undervalued intrinsic discount
23 Jul
US$66.58
Loading
1Y
87.0%
7D
16.1%

Author's Valuation

US$78.6

15.3% undervalued intrinsic discount

AnalystHighTarget Fair Value

Shared on07 May 25
Fair value Decreased 12%

Shared on30 Apr 25
Fair value Increased 14%

AnalystHighTarget made no meaningful changes to valuation assumptions.